Javascript must be enabled to continue!
Unbound fraction of vancomycin in intensive care unit patients
View through CrossRef
AbstractPublished data on the unbound fraction of vancomycin in patient samples exhibit high variability. In the present study, a robust ultrafiltration method was developed and applied to 102 clinical samples from 22 intensive care unit patients who were treated with continuous infusion of vancomycin. A validated HPLC method was used for determination of total and unbound concentrations. The mean unbound fraction was 67.2% (standard deviation 7.5%, range 47.2–92.1%) and independent of total concentration of vancomycin or of albumin. The unbound fraction was significantly correlated (r = +0.67, P = .0009) with the renally filtered fraction (drug clearance/creatinine clearance), providing functional evidence for the validity of the measurements. Ultrafiltration proved to be susceptible to variations in the experimental conditions such as pH, temperature and centrifugal force. The measured unbound fraction increased from 60% at pH 6 to 100% at pH 9, from 57% at 4°C to 80% at 37°C, and was 76% at 1,000 g compared with 45% at 10,000 g. Lack of standardization may therefore partly explain the variable results reported in the literature.
Title: Unbound fraction of vancomycin in intensive care unit patients
Description:
AbstractPublished data on the unbound fraction of vancomycin in patient samples exhibit high variability.
In the present study, a robust ultrafiltration method was developed and applied to 102 clinical samples from 22 intensive care unit patients who were treated with continuous infusion of vancomycin.
A validated HPLC method was used for determination of total and unbound concentrations.
The mean unbound fraction was 67.
2% (standard deviation 7.
5%, range 47.
2–92.
1%) and independent of total concentration of vancomycin or of albumin.
The unbound fraction was significantly correlated (r = +0.
67, P = .
0009) with the renally filtered fraction (drug clearance/creatinine clearance), providing functional evidence for the validity of the measurements.
Ultrafiltration proved to be susceptible to variations in the experimental conditions such as pH, temperature and centrifugal force.
The measured unbound fraction increased from 60% at pH 6 to 100% at pH 9, from 57% at 4°C to 80% at 37°C, and was 76% at 1,000 g compared with 45% at 10,000 g.
Lack of standardization may therefore partly explain the variable results reported in the literature.
Related Results
Immune-Mediated Thrombocytopenia in Patients Treated with Vancomycin.
Immune-Mediated Thrombocytopenia in Patients Treated with Vancomycin.
Abstract
Numerous drugs are known to cause immune thrombocytopenia (TP) mediated by antibodies (abs) that bind to platelets only when the sensitizing drug is present...
Probable Vancomycin-Induced Neutropenia
Probable Vancomycin-Induced Neutropenia
OBJECTIVE To report a case of vancomycin-induced neutropenia and provide a review of the literature. CASE SUMMARY A 64-year-old white man was treated with intravenous vancomycin 1....
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Protein binding of vancomycin in a large mixed patient population at a university hospital
Protein binding of vancomycin in a large mixed patient population at a university hospital
ABSTRACT
Vancomycin remains a key treatment for infections caused by β-lactam-resistant gram-posi...
The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study
The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study
Abstract
Background
Vancomycin is a commonly used antibiotic in critically ill patients for various indications. Critical illness imposes pharmacoki...
The Impact of Early Achievement of Therapeutic Levels of Vancomycin in Critically ill Patients with Confirmed Gram-positive Infection: A Retrospective Cohort Study
The Impact of Early Achievement of Therapeutic Levels of Vancomycin in Critically ill Patients with Confirmed Gram-positive Infection: A Retrospective Cohort Study
Abstract
Background: Vancomycin is a commonly used antibiotic in critically ill patients for various indications. Critical illness imposes pharmacokinetic-pharmacodynamics ...
P-1977. Adverse Event Profile of Vancomycin vs. Linezolid in Real-World Reports: A Disproportionality Analysis from the AERS Database
P-1977. Adverse Event Profile of Vancomycin vs. Linezolid in Real-World Reports: A Disproportionality Analysis from the AERS Database
Abstract
Background
Vancomycin and linezolid are critical agents in the treatment of multidrug-resistant gram-positive in...
The Impact of Early Achievement of Therapeutic Levels of Vancomycin in Critically Ill Patients With Confirmed Gram-Positive Infection: A Retrospective Cohort Study
The Impact of Early Achievement of Therapeutic Levels of Vancomycin in Critically Ill Patients With Confirmed Gram-Positive Infection: A Retrospective Cohort Study
Abstract
BackgroundVancomycin is a commonly used antibiotic in critically ill patients for various indications. Critical illness imposes pharmacokinetic-pharmacodynamics ch...

